HK$25m gift to fund Australia’s first CAR T-cell immunotherapy trial at University of Sydney
The Foundation has made a contribution of A$4.5 million (HK$25 million) to the University of Sydney to support Australia’s first clinical trial testing CAR T-cell immunotherapy in patients with advanced pancreatic cancer. The trial, conducted by the new Li Ka Shing Cell and Gene Initiative, is led... Read More